Search - tctmd.com

Displaying 101 - 120 of 126

Sort: Relevancy | Date

News Daily News

Major GI Events Rare but Real in Weight-Loss Patients on GLP-1 Drugs

Caitlin E. Cox

October 06, 2023

News Daily News

GLP-1 Meds Linked to 265 Reports to FDA of Suicidal Ideation: Reuters

Shelley Wood

September 28, 2023

News Conference News ESC 2023

New ESC Guidelines for CVD in Patients With Diabetes Cover Wide Ground

Caitlin E. Cox

August 30, 2023

News Daily News

SELECT: Semaglutide Cuts CV Events in Adults With Overweight or Obesity

Todd Neale

August 08, 2023

News Daily News

EMA Investigating Suicidal Thinking With GLP-1 Drugs for Weight Loss

Michael O'Riordan

July 12, 2023

News Conference News ADA 2023

Oral, Daily Semaglutide Cuts Pounds in Nondiabetic Patients: OASIS 1

Shelley Wood

June 29, 2023

News Features

Skyrocketing Popularity Puts GLP-1 Agonists for Weight Loss on Cardiology’s Radar

L.A. McKeown

May 12, 2023

News Conference News ACC 2023

Multifaceted Approach to COORDINATE Diabetes Care Improves GDMT

Yael L. Maxwell

March 07, 2023

News Conference News CRT 2023

In CABG/PCI Decisions for Left Main Disease, Diabetes ‘Still Matters’

Yael L. Maxwell

March 01, 2023

News Daily News

Semaglutide Effective for Weight Loss in Adolescents: STEP TEENS

Michael O'Riordan

December 30, 2022

News Daily News

Sky-high Cost of SGLT2i and GLP1 Agonists Deter First-line Use

L.A. McKeown

October 05, 2022

News Daily News

As US Diabetes Rates Soar, AHA Urges CV Risk Factor Control

Caitlin E. Cox

January 10, 2022

News Daily News

AHA Stresses Benefit of Meds, Surgery for Obesity-Related Hypertension

Yael L. Maxwell

September 23, 2021

News Daily News

Diabetes Duration and Meds Don’t Impact Ticagrelor Effects in THEMIS

Todd Neale

May 14, 2021

News Daily News

Fewer MACE in Diabetic Patients Taking SGLT2 Inhibitors vs DPP-4 Inhibitors

Shelley Wood

September 30, 2020

News Conference News ESC 2020

EVAPORATE: Icosapent Ethyl May Slow Atherosclerosis Progression

Yael L. Maxwell

September 02, 2020

News Daily News

New Guidance on Use of Diabetes Drugs for CVD Risk Reduction: ACC Experts

Michael O'Riordan

August 06, 2020

News Daily News

Most Secondary Prevention Patients Are Eligible for Multiple Drugs

Michael O'Riordan

January 03, 2020

News Conference News ESC 2019

New ESC Diabetes Guidelines Focus on CVD Prevention, New Drug Classes, and Low LDL

Michael O'Riordan

September 05, 2019

News Features

Top News in Heart Failure: 2018

Shelley Wood

December 28, 2018

Advertisement

Major GI Events Rare but Real in Weight-Loss Patients on GLP-1 Drugs

GLP-1 Meds Linked to 265 Reports to FDA of Suicidal Ideation: Reuters

New ESC Guidelines for CVD in Patients With Diabetes Cover Wide Ground

SELECT: Semaglutide Cuts CV Events in Adults With Overweight or Obesity

EMA Investigating Suicidal Thinking With GLP-1 Drugs for Weight Loss

Oral, Daily Semaglutide Cuts Pounds in Nondiabetic Patients: OASIS 1

Skyrocketing Popularity Puts GLP-1 Agonists for Weight Loss on Cardiology’s Radar

Multifaceted Approach to COORDINATE Diabetes Care Improves GDMT

In CABG/PCI Decisions for Left Main Disease, Diabetes ‘Still Matters’

Semaglutide Effective for Weight Loss in Adolescents: STEP TEENS

Sky-high Cost of SGLT2i and GLP1 Agonists Deter First-line Use

As US Diabetes Rates Soar, AHA Urges CV Risk Factor Control

AHA Stresses Benefit of Meds, Surgery for Obesity-Related Hypertension

Diabetes Duration and Meds Don’t Impact Ticagrelor Effects in THEMIS

Fewer MACE in Diabetic Patients Taking SGLT2 Inhibitors vs DPP-4 Inhibitors

EVAPORATE: Icosapent Ethyl May Slow Atherosclerosis Progression

New Guidance on Use of Diabetes Drugs for CVD Risk Reduction: ACC Experts

Most Secondary Prevention Patients Are Eligible for Multiple Drugs

New ESC Diabetes Guidelines Focus on CVD Prevention, New Drug Classes, and Low LDL

Top News in Heart Failure: 2018

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content